Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Overview

Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Other Income Expense Net

Other Income/Expense Net for BLACR.

Quarterly Other Income/Expense

-$252304.00

↑ 97.02% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

-$2.33M

↑ 69.13% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin